Medivation Inc (MDVN) Financial Statements (2024 and earlier)
Company Profile
Business Address |
525 MARKET STREET SAN FRANCISCO, CA 94105 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 317,361,000 | 225,853,000 | 488,944,000 | 497,507,000 | 568,636,000 | 502,677,000 | |||
Cash and cash equivalents | 317,361,000 | 225,853,000 | 488,944,000 | 421,150,000 | 568,636,000 | 502,677,000 | |||
Short-term investments | 76,357,000 | ||||||||
Restricted cash and investments | 1,140,000 | 930,000 | 930,000 | 616,000 | 930,000 | 203,000 | |||
Deferred tax assets | 22,353,000 | 9,533,000 | 20,035,000 | 21,987,000 | |||||
Other undisclosed current assets | 211,009,000 | 407,435,000 | 293,558,000 | 215,797,000 | 139,434,000 | 197,001,000 | |||
Total current assets: | 529,510,000 | 634,218,000 | 805,785,000 | 723,453,000 | 729,035,000 | 721,868,000 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 59,849,000 | 58,142,000 | 49,018,000 | 44,291,000 | 42,031,000 | 41,161,000 | |||
Long-term investments and receivables | |||||||||
Long-term investments | |||||||||
Intangible assets, net (including goodwill) | 662,942,000 | 662,942,000 | 111,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | |||
Goodwill | 18,643,000 | 18,643,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | |||
Intangible assets, net (excluding goodwill) | 644,299,000 | 644,299,000 | 101,000,000 | 101,000,000 | 101,000,000 | 101,000,000 | |||
Restricted cash and investments | 11,996,000 | 12,206,000 | 12,206,000 | 12,723,000 | 12,409,000 | 11,562,000 | |||
Other noncurrent assets | 8,037,000 | 7,072,000 | 6,957,000 | 6,355,000 | 11,845,000 | 10,852,000 | |||
Deferred tax assets, net | 53,148,000 | 57,011,000 | 35,628,000 | 32,868,000 | 18,531,000 | 15,176,000 | |||
Total noncurrent assets: | 795,972,000 | 797,373,000 | 214,809,000 | 207,237,000 | 195,816,000 | 189,751,000 | |||
TOTAL ASSETS: | 1,325,482,000 | 1,431,591,000 | 1,020,594,000 | 930,690,000 | 924,851,000 | 911,619,000 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 76,360,000 | 119,728,000 | 71,352,000 | 69,117,000 | 52,897,000 | 70,063,000 | |||
Interest and dividends payable | 305,000 | 63,000 | 1,101,000 | 3,396,000 | 1,698,000 | ||||
Taxes payable | 32,565,000 | 3,461,000 | 2,000 | 2,106,000 | |||||
Employee-related liabilities | 15,988,000 | 29,215,000 | 24,372,000 | 19,285,000 | 11,166,000 | 33,272,000 | |||
Accounts payable | 23,791,000 | 22,696,000 | 12,621,000 | 12,754,000 | 12,212,000 | 10,492,000 | |||
Accrued liabilities | 36,581,000 | 34,947,000 | 30,835,000 | 35,977,000 | 26,121,000 | 22,495,000 | |||
Debt | 316,898,000 | 738,000 | |||||||
Business combination, contingent consideration, liability | 4,924,000 | 4,900,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | |||
Deferred revenue and credits | 565,000 | 1,411,000 | 2,822,000 | ||||||
Other undisclosed current liabilities | 45,745,000 | 141,475,000 | 136,141,000 | (117,871,000) | 38,799,000 | 36,767,000 | |||
Total current liabilities: | 127,029,000 | 266,103,000 | 217,493,000 | 278,709,000 | 103,845,000 | 119,652,000 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 225,007,000 | 222,140,000 | |||||||
Long-term debt, excluding current maturities | 225,007,000 | 222,140,000 | |||||||
Liabilities, other than long-term debt | 280,961,000 | 275,403,000 | 114,528,000 | 107,538,000 | 105,705,000 | 101,827,000 | |||
Deferred tax liabilities, net | 10,000 | ||||||||
Other liabilities | 12,658,000 | 13,035,000 | 11,729,000 | 6,525,000 | 5,705,000 | 5,817,000 | |||
Business combination, contingent consideration, liability | 268,303,000 | 262,368,000 | 102,799,000 | 101,013,000 | 100,000,000 | 96,000,000 | |||
Other undisclosed noncurrent liabilities | 17,278,000 | 17,406,000 | 16,905,000 | 16,920,000 | 19,240,000 | 18,701,000 | |||
Total noncurrent liabilities: | 298,239,000 | 292,809,000 | 131,433,000 | 124,458,000 | 349,952,000 | 342,668,000 | |||
Total liabilities: | 425,268,000 | 558,912,000 | 348,926,000 | 403,167,000 | 453,797,000 | 462,320,000 | |||
Equity | |||||||||
Equity, attributable to parent | 900,214,000 | 872,679,000 | 671,668,000 | 527,523,000 | 471,054,000 | 449,299,000 | |||
Common stock | 1,646,000 | 1,639,000 | 1,636,000 | 799,000 | 786,000 | 781,000 | |||
Additional paid in capital | 707,870,000 | 684,841,000 | 626,340,000 | 561,759,000 | 531,095,000 | 506,227,000 | |||
Accumulated other comprehensive loss | (317,000) | (34,000) | |||||||
Retained earnings (accumulated deficit) | 191,015,000 | 186,199,000 | 43,692,000 | (35,001,000) | (60,827,000) | (57,709,000) | |||
Total equity: | 900,214,000 | 872,679,000 | 671,668,000 | 527,523,000 | 471,054,000 | 449,299,000 | |||
TOTAL LIABILITIES AND EQUITY: | 1,325,482,000 | 1,431,591,000 | 1,020,594,000 | 930,690,000 | 924,851,000 | 911,619,000 |
Income Statement (P&L) (USD)Annual | Quarterly
6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | ||
---|---|---|---|---|---|---|---|---|
Operating expenses | (174,414,000) | (156,348,000) | (121,680,000) | (122,002,000) | (128,615,000) | (131,253,000) | ||
Other undisclosed operating income | 182,497,000 | 377,748,000 | 260,665,000 | 175,657,000 | 129,188,000 | 274,730,000 | ||
Operating income (loss): | 8,083,000 | 221,400,000 | 138,985,000 | 53,655,000 | 573,000 | 143,477,000 | ||
Nonoperating expense | (889,000) | (460,000) | (14,135,000) | (13,229,000) | (5,471,000) | (5,501,000) | ||
Other nonoperating income (expense) | (209,000) | 28,000 | 159,000 | (82,000) | 126,000 | 68,000 | ||
Interest and debt expense | (680,000) | 11,995,000 | (14,294,000) | (13,177,000) | (5,913,000) | (5,892,000) | ||
Income (loss) from continuing operations before equity method investments, income taxes: | 6,514,000 | 232,935,000 | 110,556,000 | 27,249,000 | (10,811,000) | 132,084,000 | ||
Other undisclosed income (loss) from continuing operations before income taxes | 680,000 | (11,995,000) | 14,294,000 | 13,177,000 | 5,913,000 | 5,892,000 | ||
Income (loss) from continuing operations before income taxes: | 7,194,000 | 220,940,000 | 124,850,000 | 40,426,000 | (4,898,000) | 137,976,000 | ||
Income tax expense (benefit) | (2,378,000) | (78,433,000) | (45,340,000) | (14,600,000) | 1,780,000 | 26,229,000 | ||
Income (loss) from continuing operations: | 4,816,000 | 142,507,000 | 79,510,000 | 25,826,000 | (3,118,000) | 164,205,000 | ||
Income (loss) before gain (loss) on sale of properties: | 4,816,000 | 142,507,000 | 79,510,000 | 25,826,000 | (3,118,000) | 164,205,000 | ||
Net income (loss) available to common stockholders, basic: | 4,816,000 | 142,507,000 | 79,510,000 | 25,826,000 | (3,118,000) | 164,205,000 | ||
Other undisclosed net income available to common stockholders, diluted | 3,629,000 | 14,030,000 | ||||||
Net income (loss) available to common stockholders, diluted: | 4,816,000 | 146,136,000 | 79,510,000 | 25,826,000 | (3,118,000) | 178,235,000 |
Comprehensive Income (USD)Annual | Quarterly
6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | 4,816,000 | 142,507,000 | 79,510,000 | 25,826,000 | (3,118,000) | 164,205,000 | ||
Other comprehensive income (loss) | (317,000) | 34,000 | (34,000) | |||||
Comprehensive income (loss), net of tax, attributable to parent: | 4,499,000 | 142,507,000 | 79,544,000 | 25,792,000 | (3,118,000) | 164,205,000 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.